Neuroscience IMED is driven by external partnerships and is seeking to advance innovative programs from academic, foundation and industry partners. The Neuroscience IMED strives to offer competitive deal terms and to leverage its unique operational model to rapidly and efficiently advance the projects to key decision points or milestone-triggering events.
Our goal is to move forward collaboratively as we strive to develop new therapies and treatments that can make a meaningful difference in patients’ lives.
The Neuroscience IMED has already established collaborations with leading academic centers and companies. You can read more about these collaborative models and programs here.
If you are interested in working with the AstraZeneca Neuroscience IMED team, please contact us.